• Something wrong with this record ?

In Vitro Quantification of the Effects of IP6 and Other Small Polyanions on Immature HIV-1 Particle Assembly and Core Stability

A. Dostálková, F. Kaufman, I. Křížová, B. Vokatá, T. Ruml, M. Rumlová,

. 2020 ; 94 (20) : . [pub] 20200929

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 1967 to 6 months ago
Freely Accessible Science Journals from 1967 to 6 months ago
PubMed Central from 1967 to 1 year ago
Europe PubMed Central from 1967 to 6 months ago
Open Access Digital Library from 1967-02-01
Open Access Digital Library from 1967-02-01

Proper assembly and disassembly of both immature and mature HIV-1 hexameric lattices are critical for successful viral replication. These processes are facilitated by several host-cell factors, one of which is myo-inositol hexaphosphate (IP6). IP6 participates in the proper assembly of Gag into immature hexameric lattices and is incorporated into HIV-1 particles. Following maturation, IP6 is also likely to participate in stabilizing capsid protein-mediated mature hexameric lattices. Although a structural-functional analysis of the importance of IP6 in the HIV-1 life cycle has been reported, the effect of IP6 has not yet been quantified. Using two in vitro methods, we quantified the effect of IP6 on the assembly of immature-like HIV-1 particles, as well as its stabilizing effect during disassembly of mature-like particles connected with uncoating. We analyzed a broad range of molar ratios of protein hexamers to IP6 molecules during assembly and disassembly. The specificity of the IP6-facilitated effect on HIV-1 particle assembly and stability was verified by K290A, K359A, and R18A mutants. In addition to IP6, we also tested other polyanions as potential assembly cofactors or stabilizers of viral particles.IMPORTANCE Various host cell factors facilitate critical steps in the HIV-1 replication cycle. One of these factors is myo-inositol hexaphosphate (IP6), which contributes to assembly of HIV-1 immature particles and helps maintain the well-balanced metastability of the core in the mature infectious virus. Using a combination of two in vitro methods to monitor assembly of immature HIV-1 particles and disassembly of the mature core-like structure, we quantified the contribution of IP6 and other small polyanion molecules to these essential steps in the viral life cycle. Our data showed that IP6 contributes substantially to increasing the assembly of HIV-1 immature particles. Additionally, our analysis confirmed the important role of two HIV-1 capsid lysine residues involved in interactions with IP6. We found that myo-inositol hexasulphate also stabilized the HIV-1 mature particles in a concentration-dependent manner, indicating that targeting this group of small molecules may have therapeutic potential.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027805
003      
CZ-PrNML
005      
20211221122812.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1128/JVI.00991-20 $2 doi
035    __
$a (PubMed)32727872
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dostálková, Alžběta $u Department of Biotechnology, University of Chemistry and Technology, Prague, Prague, Czech Republic. $7 xx0267672
245    10
$a In Vitro Quantification of the Effects of IP6 and Other Small Polyanions on Immature HIV-1 Particle Assembly and Core Stability / $c A. Dostálková, F. Kaufman, I. Křížová, B. Vokatá, T. Ruml, M. Rumlová,
520    9_
$a Proper assembly and disassembly of both immature and mature HIV-1 hexameric lattices are critical for successful viral replication. These processes are facilitated by several host-cell factors, one of which is myo-inositol hexaphosphate (IP6). IP6 participates in the proper assembly of Gag into immature hexameric lattices and is incorporated into HIV-1 particles. Following maturation, IP6 is also likely to participate in stabilizing capsid protein-mediated mature hexameric lattices. Although a structural-functional analysis of the importance of IP6 in the HIV-1 life cycle has been reported, the effect of IP6 has not yet been quantified. Using two in vitro methods, we quantified the effect of IP6 on the assembly of immature-like HIV-1 particles, as well as its stabilizing effect during disassembly of mature-like particles connected with uncoating. We analyzed a broad range of molar ratios of protein hexamers to IP6 molecules during assembly and disassembly. The specificity of the IP6-facilitated effect on HIV-1 particle assembly and stability was verified by K290A, K359A, and R18A mutants. In addition to IP6, we also tested other polyanions as potential assembly cofactors or stabilizers of viral particles.IMPORTANCE Various host cell factors facilitate critical steps in the HIV-1 replication cycle. One of these factors is myo-inositol hexaphosphate (IP6), which contributes to assembly of HIV-1 immature particles and helps maintain the well-balanced metastability of the core in the mature infectious virus. Using a combination of two in vitro methods to monitor assembly of immature HIV-1 particles and disassembly of the mature core-like structure, we quantified the contribution of IP6 and other small polyanion molecules to these essential steps in the viral life cycle. Our data showed that IP6 contributes substantially to increasing the assembly of HIV-1 immature particles. Additionally, our analysis confirmed the important role of two HIV-1 capsid lysine residues involved in interactions with IP6. We found that myo-inositol hexasulphate also stabilized the HIV-1 mature particles in a concentration-dependent manner, indicating that targeting this group of small molecules may have therapeutic potential.
650    _2
$a substituce aminokyselin $7 D019943
650    _2
$a HIV-1 $x chemie $x genetika $7 D015497
650    _2
$a missense mutace $7 D020125
650    _2
$a polymery $x chemie $7 D011108
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    12
$a sestavení viru $7 D019065
650    _2
$a genové produkty gag - virus lidské imunodeficience $x chemie $x genetika $x metabolismus $7 D054301
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kaufman, Filip $u Department of Biotechnology, University of Chemistry and Technology, Prague, Prague, Czech Republic.
700    1_
$a Křížová, Ivana $u Department of Biotechnology, University of Chemistry and Technology, Prague, Prague, Czech Republic.
700    1_
$a Vokatá, Barbora $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Prague, Czech Republic.
700    1_
$a Ruml, Tomáš $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Prague, Czech Republic.
700    1_
$a Rumlová, Michaela $u Department of Biotechnology, University of Chemistry and Technology, Prague, Prague, Czech Republic michaela.rumlova@vscht.cz.
773    0_
$w MED00003048 $t Journal of virology $x 1098-5514 $g Roč. 94, č. 20 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32727872 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20211221122807 $b ABA008
999    __
$a ok $b bmc $g 1608140 $s 1118985
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 94 $c 20 $e 20200929 $i 1098-5514 $m Journal of virology $n J Virol $x MED00003048
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...